Navigation Links
Prescription Drug - Helps People Stop Smoking

The Mumbai-based Sun Pharmaceutical Industries entered the antismoking segment with its "Smoquit" (buproprion 150mg tabs) recently. The medication in Smoquit has been used for over a decade as an antidepressant, albeit at a different dose. The Rs. 13.50-per tablet priced Smoquit, the first pharmacotherapy ever available for the treatment of smoking problem, is a prescription drug and is required to be taken under medical supervision and guidance.

// Smoking causes or predisposes a person to a number of diseases such as heart disease, asthma, ulcers, and cancer. According to a WHO study, cigarettes on an average kills one of every two consumers; and by the year 2030, tobacco is likely to account for more deaths than TB and HIV put together.

The medication in Smoquit, buproprion, blocks nicotinic receptors so as to prevent the reuptake of neurotransmitters norepinephrine and dopamine. This sidesteps the problem of the urge to smoke and withdrawal symptoms, which is otherwise a hurdle when a smoker tries to quit smoking.

A study of more than 600 smokers found that use of an antidepressant drug called buproprion was a significant aid in helping subjects stop smoking. The study also found that the drug lessened the problem of weight gain among some study participants.

The patient undergoing this treatment will also require counselling from time to time. While the framework for guiding a patient through the treatment protocol is well established, the exact duration of the treatment needs to be individualized. Smoquit will be backed by an extensive patient education program, which will outline the do's and don'ts at each stage of the smoking cessation therapy.


Page: 1

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Misleading Advertisements for Prescription Drugs
3. Prescription Drug Use Varies Widely Between States
4. Does Your Prescription Have An Inappropriate Medicine?
5. More Errors From Computerized Prescriptions
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. Malaria May Gain Resistance To Single Drug Prescriptions
8. Prescription For Cancer Drugs Cost Dearer Than Life
9. Middle-Aged Women with Headaches, Often Walk Out With Prescriptions
10. Prescription to NHS: Nourish the Malnourished, For a Well-Fed Economy!
11. A 15p increase in an NHS Prescription Cost
Post Your Comments:

(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: